Encision Inc (ECIA) stock
ECIAOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$0.01+0.00 (0.00%)
Close on Oct 19, 2026Market cap $163.15KP/E –Yield –
Encision operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Encision's operating income for the twelve months ending Sep 30, 2025 was -$319.68K. For fiscal 2025 it was -$171.98K. The highest annual figure on record is $395.83K in fiscal 2018.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | -$171.98K | – |
| FY2024 | Mar 31, 2024 | -$640.78K | – |
| FY2023 | Mar 31, 2023 | -$302.80K | – |
| FY2022 | Mar 31, 2022 | -$594.93K | – |
| FY2021 | Mar 31, 2021 | -$61.64K | – |
| FY2020 | Mar 31, 2020 | -$156.36K | – |
| FY2019 | Mar 31, 2019 | -$186.36K | -147.1% |
| FY2018 | Mar 31, 2018 | $395.83K | – |
| FY2017 | Mar 31, 2017 | -$688.24K | – |
| FY2016 | Mar 31, 2016 | -$708.36K | – |
| FY2015 | Mar 31, 2015 | -$1.18M | – |
| FY2014 | Mar 31, 2014 | -$1.51M | – |
| FY2013 | Mar 31, 2013 | -$549.55K | – |
| FY2012 | Mar 31, 2012 | -$472.35K | -1043.2% |
| FY2011 | Mar 31, 2011 | $50.08K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -$258.49K | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$19.78K | -169.8% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$20.54K | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$20.87K | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$158.92K | -2732.8% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $28.34K | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$329.53K | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$189.40K | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $6.04K | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$127.89K | -147.9% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$79.83K | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$211.47K | – |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$278.40K | – |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $266.90K | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$402.95K | -363.2% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$16.27K | -227.7% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | -$170.62K | – |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$5.10K | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $153.10K | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $12.74K | -85.2% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -$78.02K | -322.0% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$149.46K | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$98.38K | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $86.16K | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $35.14K | -12.9% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$179.28K | -566.9% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$180.90K | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | -$84.18K | -218.1% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $40.33K | -68.8% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $38.40K | -80.6% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$2.45K | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $71.29K | – |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $129.35K | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $197.64K | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | -$101.58K | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | -$257.78K | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | -$243.72K | – |
| Q1 FY2017CQ2 2016 | Jun 30, 2016 | -$85.17K | – |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | -$267.35K | – |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | -$146.14K | – |
See a number that looks wrong?